Sage Journals: Discover world-class research

Free access

Research article

First published 2001-09

Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter

Marc M. Rahme, GilAnthony Ungab, Manish Wadhwa [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Research article

First published 1989-6

Broad Sensitivity of Rodent Arrhythmia Models to Class I,II,III,and IV Antiarrhythmic Agents

Robert R. Brooks, Kim E. Miller, John F. Carpenter [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 1996-9

Class III Antiarrhythmic Effects of Dofetilide in Rabbit Atrial Myocardium

Regan T. Pallandi, Nigel H. Lovell, Terence J. Campbell

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Research article

First published 1997-3

The Novel Class III Antiarrhythmic Agent MS-551 Blocks the Cardiac Inward Rectifier With Greater Potency Than Sotalol or E-4031: Possible Relevance to Reverse Use Dependence

Yutaka Nakaya, Donald K. Martin, Terence J. Campbell

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Review article

First published 2000-1

Dofetilide: A Class III-Specific Antiarrhythmic Agent

James S Kalus, Vincent F Mauro

Annals of Pharmacotherapy

Retricted access

Research article

First published 1996-5

Efficacy of the Class III Antiarrhythmic Agent Azimilide in Rodent Models of Ventricular Arrhythmia

Robert R. Brooks, John F. Carpenter, Kim E. Miller [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 2000-2

Proarrhythmia of Azimilide and Other Class III Antiarrhythmic Agents in the Adrenergically Stimulated Rabbit (44478)

Robert R. Brooks, Anne P. Drexler, Anne E. Maynard [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 1997-9

Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation

Gregory K. Feld, Yongmei Cha

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Review article

First published 2000-12

Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide

Shephal K. Doshi, Bramah N. Singh

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Research article

First published 1997-12

Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should They Be?

Bramah N. Singh

Journal of Cardiovascular Pharmacology and Therapeutics

Search results